Mitrakou A, Fanelli C, Veneman T, Perriello G, Calderone S, Platanisiotis D, Rambotti A, Raptis S, Brunetti P, Cryer P
Second Department of Internal Medicine, Propaedeutic, Athens University, Greece.
N Engl J Med. 1993 Sep 16;329(12):834-9. doi: 10.1056/NEJM199309163291203.
A lack of appropriate autonomic warning symptoms before the development of neuroglycopenia occurs frequently in patients with diabetes mellitus. The pathogenesis of this phenomenon is unclear, but it is associated with intensive insulin therapy, prolonged duration of diabetes, frequent episodes of hypoglycemia, and impaired glucose counterregulation. Recently, it has been proposed that repeated episodes of hypoglycemia may themselves induce the phenomenon.
To test this hypothesis and to determine whether the phenomenon is reversible, we assessed autonomic and neuroglycopenic symptoms, counterregulatory hormonal responses, and cognitive function during stepped hypoglycemic-clamp studies in 6 patients with insulinomas before and approximately six months after curative surgery and in 14 normal subjects matched for age, weight, and sex.
Before surgery, the patients with insulinomas had lower scores than the normal subjects for autonomic symptoms (mean [+/- SD], 3.5 +/- 0.8 vs. 9.6 +/- 4.5) and neuroglycopenic symptoms (2.8 +/- 1.5 vs. 8.9 +/- 5.3). The patients also had impaired counterregulatory hormonal responses (their plasma epinephrine, norepinephrine, glucagon, growth hormone, and cortisol responses before surgery were 187 +/- 227 pg per milliliter [1.03 +/- 1.25 nmol per liter], 223 +/- 85 pg per milliliter [1.32 +/- 0.50 nmol per liter], 86 +/- 21 ng per liter, 7.4 +/- 5.2 micrograms per liter, and 12.1 +/- 1.5 micrograms per deciliter [334 +/- 41 nmol per liter], respectively, as compared with 842 +/- 439 pg per milliliter [4.63 +/- 2.41 nmol per liter], 519 +/- 150 pg per milliliter [3.07 +/- 0.89 nmol per liter], 201 +/- 58 ng per liter, 25.3 +/- 13.7 micrograms per liter, and 26.3 +/- 1.2 micrograms per deciliter [726 +/- 33 nmol per liter] in the normal subjects) and less deterioration in cognitive function than the normal subjects during hypoglycemia (sum of z scores for seven tests of cognitive function, 1.7 +/- 1.9 vs. 8.9 +/- 3.5) (P < 0.02 for all comparisons). Surgical cure reversed all these abnormalities (P not significant for all comparisons with the normal subjects).
Hypoglycemia itself can induce unawareness of the autonomic and neuroglycopenic symptoms of hypoglycemia and decrease the counterregulatory hormonal responses to hypoglycemia.
糖尿病患者在发生低血糖性脑缺糖之前,常常缺乏适当的自主神经预警症状。这种现象的发病机制尚不清楚,但与强化胰岛素治疗、糖尿病病程延长、频繁发生低血糖以及葡萄糖反向调节受损有关。最近,有人提出反复发生低血糖本身可能会诱发这种现象。
为了验证这一假设并确定该现象是否可逆,我们在6例胰岛素瘤患者根治性手术前和术后约6个月进行逐步低血糖钳夹研究期间,评估了他们的自主神经和低血糖性脑缺糖症状、反向调节激素反应以及认知功能,并与14名年龄、体重和性别相匹配的正常受试者进行了比较。
手术前,胰岛素瘤患者的自主神经症状评分(平均值[±标准差],3.5±0.8对9.6±4.5)和低血糖性脑缺糖症状评分(2.8±1.5对8.9±5.3)低于正常受试者。这些患者的反向调节激素反应也受损(他们术前血浆肾上腺素、去甲肾上腺素、胰高血糖素、生长激素和皮质醇的反应分别为每毫升187±227皮克[1.03±1.25纳摩尔/升]、每毫升223±85皮克[1.32±0.50纳摩尔/升]、每升86±21纳克、每升7.4±5.2微克以及每分升12.1±1.5微克[334±41纳摩尔/升],而正常受试者分别为每毫升842±439皮克[4.63±2.41纳摩尔/升]、每毫升519±150皮克[3.07±0.89纳摩尔/升]、每升201±58纳克、每升25.3±13.7微克以及每分升26.3±1.2微克[726±33纳摩尔/升]),并且在低血糖期间认知功能的恶化程度低于正常受试者(认知功能七项测试的z评分总和,1.7±1.9对8.9±3.5)(所有比较P<0.02)。手术治愈后,所有这些异常情况均得到逆转(与正常受试者的所有比较P均无统计学意义)。
低血糖本身可导致对低血糖自主神经和低血糖性脑缺糖症状的无察觉,并降低对低血糖的反向调节激素反应。